Metuchen Therapeutics, LLC - 23 Mar 2021 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role: 10%+ Owner
Signature: [see signatures attached as Exhibit 99.1]
Issuer symbol: PTPI
Transactions as of: 23 Mar 2021
Net transactions value: $0
Form type: 4
Filing time: 20 Oct 2021, 21:59:32 UTC
SEC: View on sec.gov

Metuchen Therapeutics, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

(1) On March 23, 2021, Metuchen Therapeutics, LLC distributed all 273,213 shares of Common Stock held of record by MT to its respective members. As a result, the reporting person is no longer subject to Section 16 in connection with transactions in the equity securities of Petros Pharmaceuticals, Inc. and therefore will no longer report any such transactions on Form 4 or Form 5.